A sustained shift toward healthier diets can improve life expectancy.
Lilly unveils more positive late-stage data for its once-weekly insulin
On Thursday, Eli Lilly dropped more data for its once-weekly insulin candidate in adults with type 2 diabetes. In two Phase 3 trials, dubbed QWINT